Immunotherapy Drugs Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Growing Demand for Monoclonal Antibodies and Biosimilars
   3. Market Restraints
      1. High Treatment Costs
      2. Complex Manufacturing and Regulatory Challenges
   4. Market Opportunity
      1. Developments in Biotechnology and Personalized Medicine
   5. Market Trends
      1. Expansion of Combination Therapies
      2. Rise of Biosimilars and Biobetters
5. MARKET SEGMENTATION
   1. By Type
      1. Monoclonal Antibodies
      2. Checkpoint Inhibitors
      3. Interferons& Interleukins
      4. Other Immunotherapies
   2. By Therapy Area
      1. Cancer
      2. Autoimmune & Inflammatory Diseases
      3. Infectious Diseases
      4. Other Therapeutic Areas
   3. By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
   4. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Amgen Inc.
      2. AstraZeneca
      3. AbbVie Inc.
      4. BoehringerIngelheim
      5. Bayer
      6. BioNTech SE
      7. Bristol-Myers Squibb
      8. F. Hoffmann-La Roche Ltd.
      9. GlaxoSmithKline Plc
      10. Genmab
      11. Gilead Sciences
      12. Immatics Biotechnologies
      13. Johnson & Johnson
      14. Merck & Co.
      15. NBE Therapeutics
      16. Novartis International AG
      17. Pfizer Inc.
      18. Sanofi
      19. Teva Pharmaceuticals
7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Immunotherapy Drugs market?

The global market of immunotherapy drugsis projected to reach USD 272 Bnby 2033.

Q.2. What is the estimated growth rate (CAGR) of the global Immunotherapy Drugs market?

The global immunotherapy drugsmarket has an estimated annual growth rate of 8.5%.

Q.3. What are the recent trends of Immunotherapy Drugs market?

Expansion of combination therapies and rise of biosimilars and biobettersare some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in Immunotherapy Drugs?

The major companies profiled in this report include Amgen Inc., AstraZeneca, AbbVie Inc., BoehringerIngelheim, Bayer, BioNTech SE, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Genmab, Gilead Sciences, Immatics Biotechnologies, Johnson & Johnson, Merck & Co, NBE Therapeutics, Novartis International AG, Pfizer Inc., Sanofi, Teva Pharmaceuticals, among others.  

Q.5. Which is the largest regional market in the Immunotherapy Drugs?

North America is the largest regional market for immunotherapy drugs.